Levi Strauss Stock Surges After Raised Outlook; JPMorgan Bumps Price Target

Levi Strauss (LEVI) shares surged 11% to a 52-week high after the denim retailer reported stronger-than-expected fiscal second-quarter earnings and raised its full-year outlook. JPMorgan analysts subsequently increased their price target for LEVI from $18 to $23, citing management's confirmation of sustained business momentum across all regions and segments, which has alleviated previous concerns regarding tariff impacts.

Analysis

Levi Strauss (LEVI) experienced a significant positive market reaction, with its stock surging 11% to a 52-week high, following a fiscal second-quarter earnings report that surpassed estimates and an upward revision to its full-year guidance. The performance was underpinned by broad-based fundamental strength, as sales increased across all geographic regions and in both its men's and women's segments. A key operational highlight is the brand's achievement of becoming the #1 women's denim brand over the last 12 months, signaling strong market share gains and consumer resonance. This robust performance prompted a notable analyst revision from JPMorgan, which raised its price target to $23 from $18, positioning its outlook above the Visible Alpha consensus of $20.63. The upgrade is directly supported by management's commentary indicating "no signs of moderation in business momentum," which alleviates prior analyst concerns over potential headwinds, including the impact of tariffs, which the company plans to mitigate with "surgical" price adjustments rather than broad-based increases.

Key Decisions for Investors

• Given the strong earnings beat, raised full-year outlook, and positive price target revision, investors could view the current momentum as supportive for initiating or adding to long positions.
• Investors should closely monitor future earnings reports for sustained growth, particularly in the now #1 ranked women's segment, to validate management's optimistic outlook.
• While management has outlined a targeted approach, the actual implementation and consumer impact of any tariff-related price increases remain a primary risk factor to monitor.
• With the stock at a 52-week high, consider the new $23 price target from JPMorgan as a key level, weighing its premium over the analyst consensus when evaluating further upside potential.